Core Points - GE HealthCare Technologies Inc. declared a cash dividend of $0.035 per share for the fourth quarter of 2025, payable on February 13, 2026, to shareholders of record as of January 9, 2026 [1] - GE HealthCare is a leading global healthcare solutions provider with a focus on medical technology, pharmaceutical diagnostics, and AI-enabled solutions, generating approximately $19.7 billion in revenue and employing around 53,000 people [2] - The company aims to enhance healthcare efficiency and patient outcomes through its various business segments, including Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics [2] Company Overview - GE HealthCare has been a trusted partner in healthcare for over 125 years, focusing on personalized and connected care while simplifying patient journeys [2] - The company is recognized as one of the 2025 Fortune World's Most Admired Companies [3] Recent Developments - GE HealthCare announced the acquisition of Intelerad, a medical imaging software provider, for $2.3 billion in cash, which aligns with its strategy to enhance cloud-enabled and AI-powered solutions [6] - The company is committed to tripling its offerings of cloud-enabled products by 2028 [6] - GE HealthCare management will present at the Jefferies Global Healthcare Conference on November 18, 2025, discussing business strategy and growth opportunities [7]

Core Insights - GE HealthCare has submitted a 510(k) application to the U.S. FDA for its new photon-counting computed tomography (PCCT) system, Photonova Spectra, which incorporates advanced AI algorithms [1] - This submission represents a significant milestone in GE HealthCare's long history of innovation in computed tomography [1] - Photonova Spectra utilizes GE HealthCare's proprietary Deep Silicon detector technology, aiming to provide exceptional spectral and spatial resolution for ultra-high-definition imaging [1]